Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on pet

American Journal of Transplantation

Volumn 9, Issue 11, 2009, Pages 2631-2636

  Kornberg, A ^a   Kupper B ^a   Thrum, K ^a   Wilberg, J ^a   Sappler, A ^a   Gottschild, D ^b  

^a Visceral and Vascular Surgery ^*  (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

18 F FDG positron emission tomography; Cholangiocarcinoma; Clinical study; Hilar cholangiocarcinoma; Liver cancer; Liver transplantation; PET; Recurrent diseases after transplantation; Tumor recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KLATSKIN TUMOR; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PATIENT ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 70350126604     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02821.x     Document Type: Article

References (22)

1. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992 215 : 31 38.
2. Kondo S, Hirano S, Ambo Y et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: Results of a prospective study. Ann Surg 2004 240 : 95 101.
3. Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Tusch G, Ringe B. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996 224 : 628 638.
4. Iwatsuki S, Todo S, Marsh JW et al. Treatment of hilar cholangiocarcinoma (Klatskin tumor) with hepatic resection or transplantation. J Am Coll Surg 1998 187 : 358 364.
5. Rea D, Heimbach JK, Rosen CB et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005 242 : 451 458.
6. Heimbach JK, Gores GJ, Haddock MG et al. Predictors of disease recurrence following neoadjuvant chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006 82 : 1703 1707.
7. Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am 2001 39 : 883 917.
8. Okazumi S, Isono K, Enomoto K et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: Characterization of tumor and assessment of effect of treatment. J Nucl Med 1992 33 : 333 339.
9. 18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant 2009 9 : 592 600.
10. Breitenstein S, Apestegui C, Clavien PA. Positron emission tomography (PET) for cholangiocarcinoma. HPB 2008 10 : 120 121.
11. Fritscher-Ravens A, Bohuslavizki KH, Broering DC et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001 22 : 1277 1285.
12. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975 140 : 170 178.
13. Sobin LH, Wittekind C, eds. TNM classification of malignant tumors, 5th Ed. New York : Wiley, 1997.
14. Rosen CB, Heimbach JK, Gores GJ. Surgery for cholangiocarcinoma: The role of liver transplantation. HPB 2008 10 : 186 189.
15. Lang H, Sotiropoulos GC, Kaiser GM, Molmenti EP, Malago M, Broelsch CE. The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB 2005 7 : 268 272.
16. Corvera CU, Blumgart LH, Akhurst T et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancers. J Am Coll Surg 2008 206 : 57 65.
17. Kato T, Tsukamoto E, Kuge Y et al. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 2002 29 : 1047 1054.
18. Seo S, Hatano E, Higashi T et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Surgery 2008 143 : 769 777.
19. Jonas S, Mittler J, Pascher A et al. Extended indication of living-donor liver transplantation: Bile duct cancer. Transplantation 2005 80 : S101 S104.
20. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990 33 : 610 614.
21. Yokoyama I, Carr B, Saitsu H et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991 68 : 2095 2100.
22. Sudan D, DeRoover A, Chinnakotla S et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002 2 : 774 779.